Clinical Trial Update: Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on CD19 CAR-T therapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) (CD19 CAR-T)

Snippet

Sponsor: Acibadem University | Conditions: Acute Lymphoblastic Leukemia, Non Hodgkin Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN